202 related articles for article (PubMed ID: 15942841)
21. [Diagnostic strategy and treatment planning in bronchial cancer].
Drings P
Radiologe; 1990 Apr; 30(4):149-54. PubMed ID: 2160669
[TBL] [Abstract][Full Text] [Related]
22. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
Van Meerbeeck JP; De Pauw R; Tournoy K
Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
[TBL] [Abstract][Full Text] [Related]
23. Non-small cell lung cancer in the elderly.
Makrantonakis PD; Galani E; Harper PG
Oncologist; 2004; 9(5):556-60. PubMed ID: 15477641
[TBL] [Abstract][Full Text] [Related]
24. [Does prophylactic whole-brain irradiation in small-cell bronchial carcinoma at the "limited disease" stage improve overall survival?].
Rübe C
Strahlenther Onkol; 1996 Mar; 172(3):176-7. PubMed ID: 8721269
[No Abstract] [Full Text] [Related]
25. [Response judgement - conventional versus new methods].
Diederich S; Engeser P; Junker K; Passlick B; Pfluger T; Pottgen C; Reck M
Onkologie; 2009; 32 Suppl 1():9-17. PubMed ID: 19521130
[TBL] [Abstract][Full Text] [Related]
26. Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancer.
Manser RL; Wright G; Byrnes G; Hart D; Conron M; Carter R; McLachlan SA; Campbell DA
Lung Cancer; 2006 Aug; 53(2):217-29. PubMed ID: 16765475
[TBL] [Abstract][Full Text] [Related]
27. Clinical trials referral resource. Clinical trials in lung cancer.
Feigal EG; Cheson BD; Nelson AP
Oncology (Williston Park); 1997 Nov; 11(11):1686, 1688, 1691, 1694. PubMed ID: 9394366
[No Abstract] [Full Text] [Related]
28. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
van Meerbeeck JP; Surmont VF
Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
[TBL] [Abstract][Full Text] [Related]
29. [Detection and prognostic significance of micrometastasis in peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation therapy].
Chen TF; Jiang GL; Zhang YQ; Wang LJ; Fu XL; Qian H; Wu KL; Zhao S
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):365-8. PubMed ID: 17892133
[TBL] [Abstract][Full Text] [Related]
30. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
31. [Possible role of autotransplantation in small cel bronchial carcinoma].
Tiefengraber E; Sebesta C; Kier P; Ruckser R; Habertheuer KH; Hinterberger W
Wien Med Wochenschr; 1995; 145(2-3):50-2. PubMed ID: 7762253
[TBL] [Abstract][Full Text] [Related]
32. Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer.
Butts C; Murray N; Maksymiuk A; Goss G; Marshall E; Soulières D; Cormier Y; Ellis P; Price A; Sawhney R; Davis M; Mansi J; Smith C; Vergidis D; Ellis P; MacNeil M; Palmer M
J Clin Oncol; 2005 Sep; 23(27):6674-81. PubMed ID: 16170175
[TBL] [Abstract][Full Text] [Related]
33. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA
Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
[TBL] [Abstract][Full Text] [Related]
34. The role of epoetin beta in the treatment of anaemia in patients with gynaecological malignancies.
Cornes P; Boiangiu I
Anticancer Res; 2007; 27(1B):513-22. PubMed ID: 17348435
[TBL] [Abstract][Full Text] [Related]
35. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
36. A novel diagram and complement to the CONSORT chart for presenting multimodal clinical trials.
Schuller JC; Mayer M; Lanz D; Schmitz SF; Brauchli P; Leupin N
Contemp Clin Trials; 2009 May; 30(3):201-4. PubMed ID: 19470310
[TBL] [Abstract][Full Text] [Related]
37. Once-weekly epoetin beta (30,000 IU) in anemic patients with lung cancer receiving chemotherapy.
Pirker R; Lehnert M; Minar W
Lung Cancer; 2007 Jan; 55(1):89-94. PubMed ID: 17084484
[TBL] [Abstract][Full Text] [Related]
38. Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers.
Berardi R; Brunelli A; Tamburrano T; Verdecchia L; Onofri A; Zuccatosta L; Gasparini S; Santinelli A; Scartozzi M; Valeri G; Giovagnoni A; Giuseppetti GM; Fabris G; Marmorale C; Fianchini A; Cascinu S
Lung Cancer; 2005 Sep; 49(3):371-6. PubMed ID: 15951051
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer treatment present and future.
Cho JK
Hawaii Med J; 2003 Mar; 62(3):61-2. PubMed ID: 12703177
[No Abstract] [Full Text] [Related]
40. Measurement and management of health-related quality of life in lung cancer.
Davis K; Yount S; Wagner L; Cella D
Clin Adv Hematol Oncol; 2004 Aug; 2(8):533-40. PubMed ID: 16163227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
